Application 209855
- Type
- ANDA
- Sponsor
- IPCA LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | TABLET;ORAL | 600MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | TABLET;ORAL | 800MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209855-001 | GABAPENTIN | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | ||
| A209855-002 | GABAPENTIN | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2024-05-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2024-05-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2024-05-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2024-05-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2024-05-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2024-05-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2024-05-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2024-05-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2024-05-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2024-05-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2024-05-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2024-05-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2024-05-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2024-05-29 | 1e350fbaab3a… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209855-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2024-05-29 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209855-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2024-05-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209855-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209855-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209855-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209855-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209855-001 | AB1 | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209855-002 | AB1 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209855-001 | AB1 | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209855-002 | AB1 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209855-001 | AB1 | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209855-002 | AB1 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209855-001 | AB1 | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209855-002 | AB1 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209855-001 | AB1 | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209855-002 | AB1 | 1 | 1e350fbaab3a… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Direct_Rx | ed9c501c-24e4-da89-e053-2a95a90a64c6 | 2025-06-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 11645bd6-7cfe-49b2-9292-2e4b0dbb84ae | 2025-06-04 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | 969cccfc-e56a-49da-9d36-47c0c3fad7f8 | 2025-06-03 | Warnings, Adverse reactions | gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | PAI Holdings, LLC dba PAI Pharma | 6d3fd1f9-c831-4262-af10-291838a53541 | 2025-05-31 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | 8215da86-d7af-4980-b6d6-4bd46f6bfeaf | 2025-05-30 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | ATLANTIC BIOLOGICALS CORP. | 5969f1a8-d6d5-4967-add5-4e2492354d7b | 2025-05-27 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | 0ce53f62-1738-43f4-9a2e-c5dc42a91d09 | 2025-05-26 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 7d3fc163-25f0-2c61-e053-2991aa0a76e9 | 2025-05-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Granules Pharmaceuticals Inc. | e847bcfa-f3de-404a-8a57-d8a414691e6a | 2025-05-14 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals LLC | 772d9e7a-3811-455a-99e6-f2a3d0769b9b | 2025-05-13 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Aurobindo Pharma Limited | 1a619a14-0b63-4cba-80e7-474c9a1c90b9 | 2025-05-12 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Aurobindo Pharma Limited | 25cf6c40-a239-4dd0-9cad-28da84d285db | 2025-05-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 3c8dca11-78ab-45c1-8bb2-89a41ea5dfa9 | 2025-05-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals, Inc. | 41d1ead3-046e-4abf-ae0a-cb126a1f5848 | 2025-05-01 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Actavis Pharma, Inc. | 5969871e-6c71-4c37-9d63-370718ccc80c | 2025-05-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Cipla USA Inc. | 9e4eca9c-6a2c-4ede-a252-1a27094bf594 | 2025-05-01 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Direct_Rx | 30a2ed14-dcda-f972-e063-6294a90a417c | 2025-04-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | McKesson Corporation dba Sky Packaging | 23eb133e-2f74-4219-9892-0a8e770ec032 | 2025-04-17 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Mylan Pharmaceuticals Inc. | cff7de45-148b-4e96-88fd-6052bf75b5f7 | 2025-04-12 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Westminster Pharmaceuticals, LLC | 3ad96553-73a4-4a9b-8a89-10a29b794ed3 | 2025-04-04 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.